US HB7823 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 12-0)
Status: Introduced on March 26 2024 - 25% progression
Action: 2024-03-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 26 2024 - 25% progression
Action: 2024-03-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.
Title
Second Chance for Moms Act
Sponsors
| Rep. Mary Miller [R-IL] | Rep. Brian Babin [R-TX] | Rep. Harriet Hageman [R-WY] | Rep. Matt Rosendale [R-MT] |
| Rep. Diana Harshbarger [R-TN] | Rep. Jim Banks [R-IN] | Rep. Daniel Webster [R-FL] | Rep. Doug LaMalfa [R-CA] |
| Rep. Andrew Clyde [R-GA] | Rep. Doug Lamborn [R-CO] | Rep. Paul Gosar [R-AZ] | Rep. Keith Self [R-TX] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-03-29 | House | Referred to the Subcommittee on Health. |
| 2024-03-26 | House | Referred to the House Committee on Energy and Commerce. |
| 2024-03-26 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/7823/all-info |
| Text | https://www.congress.gov/118/bills/hr7823/BILLS-118hr7823ih.pdf |
